NET of unknown primary
Revision as of 16:19, 22 March 2018 by Warner-admin (talk | contribs) (Text replacement - "?Variant |limit=10000|format=sum}} variants" to "?Variant |limit=10000|format=sum}} variants")
0 regimens on this page
0 variants on this page
|
Guidelines
ESMO
- Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015) PubMed
NCCN
All lines of therapy
- Poorly differentiated or small cell tumors can be treated with small cell lung cancer regimens.
- Moderate to well-differentiated neuroendocrine tumors can be treated with regimens for neuroendocrine tumors.